Genmab — Juli 2018

[GeorgeBest]

Tak Bulder, så er der håb denne gang

[JKY_VH]

Jo det kan vi da håbe på og tak Bulder;-)

[Bulder]

Ixazomib velegnet som vedligeholdelse efter asct. https://myelomaresearchnews.com/2018/07/18/ninlaro-maintenance-therapy-fares-well-multiple-myeloma-trial/?utm_source=Myeloma+List&utm_campaign=92b3ddc899-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_14fcd0022a-92b3ddc899-72491777

[E_L]

this is the Public summary pdf on the granting of orphan designation for Dara for the treatment of AL amyloidosis we saw a few weeks ago, not sure if we posted it yet http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2018/07/WC500252417.pdf

[E_L]

Expert Highlights Current and Emerging Immunotherapy Treatment Options in Multiple Myeloma https://www.targetedonc.com/news/expert-highlights-current-and-emerging-immunotherapy-treatment-options-in-multiple-myeloma

[Bulder]

Nogen der ved om ixazomib er blevet testet head to head mod bortezomib?

[Bulder]

Der kører flere fase 2 studier med dara-ixa både i 1. linje og relapsed.

[Plimsoller]

God morgen

[transalp]

Go morgen:)

[bibob]

God morgen.

[polle1]

God morgen

[E_L]

this shows that the JNJ-63723283 - Dara study that was halted had only enrolled 10 patients https://clinicaltrials.gov/ct2/history/NCT03357952?A=7&B=8&C=merged

[E_L]

the (D-RVd) vs (RVd) is now set to an actual recruitment of 224 https://clinicaltrials.gov/ct2/history/NCT02874742?A=24&B=25&C=merged

[E_L]

this atezolizumab for MM trial was also updated https://clinicaltrials.gov/ct2/history/NCT02431208?A=39&B=40&C=merged

[E_L]

they also added 1 arm, which inlcudes Dara

[Bulder]

You already posted that last friday

[MarsFars]

Agurketid

[E_L]

ah sorry, i thought i posted the NSCLC last Friday, thx
https://clinicaltrials.gov/ct2/history/NCT03023423?A=20&B=21&C=merged

[E_L]

i do remember also writing something like, there are more updates, but even during Agurketid nobody could be bothered to check lol

[E_L]

Lonial Lays Out Optimal Sequence Strategies for Relapsed/Refractory Myeloma https://www.onclive.com/conference-coverage/pplc-2018/lonial-lays-out-optimal-sequence-strategies-for-relapsedrefractory-myeloma